Publications 2019

Neesgaard B, Pelchen-Matthews A, Ryom L, Florence E, Peters L, Roen A, Svedhem V, Clarke A, Benfield T, Mitsura V, Moreno S, Beniowski M, Begovac J, Matulionyte R, Trofimova T, Elbirt D, Kundro M, Vullo V, Behrens G, Staub T, Ragone L, Vannappagari V, Lundgren J, Mocroft A, Schmied B et al. (2019)
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe
Aids, 33 (13), 2013-2024
DOI 10.1097/QAD.0000000000002320

Schwartz T, Jensenius M, Blomberg B, Fladeby C, Mæland A, Pettersen FO (2019)
Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
Trop Dis Travel Med Vaccines, 5, 16
DOI 10.1186/s40794-019-0092-x, PubMed 31463070

Publications 2016

Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
Hepatitis C reinfection after sustained virological response
J Hepatol, 64 (5), 1020-1026
DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289

Publications 2014

Maeland A (2014)
Antiretroviral treatment initiation
Lancet Infect Dis, 14 (12), 1175
DOI 10.1016/S1473-3099(14)70947-8, PubMed 25455976

Publications 2013

Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
Bayesian estimation of HIV-1 dynamics in vivo
Math Med Biol, 32 (1), 38-55
DOI 10.1093/imammb/dqt018, PubMed 24078026

Publications 2010

Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
[Syphilis and blood transfusion]
Tidsskr Nor Laegeforen, 130 (8), 839-41
DOI 10.4045/tidsskr.08.0188, PubMed 20418930

Publications 2009

Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
DOI 10.1128/JCM.00519-09, PubMed 19420166

Publications 2007

Jensenius M, Maeland A, Brubakk O (2007)
Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
Travel Med Infect Dis, 6 (1-2), 45-7
DOI 10.1016/j.tmaid.2007.09.043, PubMed 18342274

Publications 2006

Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
[HIV/AIDS--from lethal syndrome to chronic disease]
Tidsskr Nor Laegeforen, 126 (23), 3121-4
PubMed 17160119

Skeie L, Maeland A (2006)
Can efavirenz be taken in the morning?
Scand J Infect Dis, 38 (11-12), 1089-91
DOI 10.1080/00365540600794386, PubMed 17148083

Publications 2003

Maeland A, Ronnestad I, Waagbo R (2003)
Folate in eggs and developing larvae of Atlantic halibut, Hippoglossus hippoglossus L.
Aquac. Nutr., 9 (3), 185-188
DOI 10.1046/j.1365-2095.2003.00242.x

Publications 2002

Bjøro K, Bell H, Hellum K, Skaug K, Raknerud N, Sandvei P, Døskeland B, Mæland A, Lund-Tønnesen S, Myrvang B (2002)
Effect of combined interferon-alpha induction therapy andribavirin on chronic hepatitis C virus infection: a randomized multicentre study
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 37(2002)nr 2, s. 226-232
BIBSYS 031205933

Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
Scand J Gastroenterol, 37 (2), 226-32
DOI 10.1080/003655202753416920, PubMed 11843062

Bruun JN, Maeland A (2002)
[Mother-to-child transmission of HIV]
Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
PubMed 12043061

Publications 2001

Ormaasen V, Maeland A (2001)
[Tuberculosis among HIV-infected persons in Norway]
Tidsskr Nor Laegeforen, 121 (29), 3425-30
PubMed 11826791

Publications 2000

Maeland A, Ronnestad I, Fyhn HJ, Berg L, Waagbo R (2000)
Water-soluble vitamins in natural plankton (copepods) during two consecutive spring blooms compared to vitamins in Artemia franciscana nauplii and metanauplii
Mar. Biol., 136 (5), 765-772
DOI 10.1007/s002270000280

Olsen AI, Maeland A, Waagbo R, Olsen Y (2000)
Effect of algal addition on stability of fatty acids and some water-soluble vitamins in juvenile Artemia franciscana
Aquac. Nutr., 6 (4), 263-273
DOI 10.1046/j.1365-2095.2000.00157.x

Publications 1999

Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
Scand J Gastroenterol, 34 (2), 194-8
DOI 10.1080/00365529950173087, PubMed 10192200

Maeland A, Rosenlund G, Stoss J, Waagbo R (1999)
Weaning of Atlantic halibut Hippoglossus hippoglossus L. using formulated diets with various levels of ascorbic acid
Aquac. Nutr., 5 (3), 211-219

Maeland A, Sandnes K (1999)
Determination of biotin in low-temperature fish-meal processed from different species by means of a microbiological method using Lactobacillus plantarum as test organism
J. Sci. Food Agric., 79 (10), 1298-1300

Publications 1998

Brantsaeter AB, Hoel T, Kristianslund TI, Maeland A (1998)
[Tularemia after tick bite in Vestfold]
Tidsskr Nor Laegeforen, 118 (8), 1191-3
PubMed 9567695

Jarvis LM, Bell H, Simmonds P, Hawkins A, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K (1998)
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
Scand J Gastroenterol, 33 (2), 195-200
DOI 10.1080/00365529850166941, PubMed 9517532

Maeland A, Waagbo R (1998)
Examination of the qualitative ability of some cold water marine teleosts to synthesise ascorbic acid
Comp. Biochem. Physiol. A-Mol. Integr. Physiol., 121 (3), 249-255
DOI 10.1016/S1095-6433(98)10125-3

Maeland A, Waagbo R, Sandnes K, Hjeltnes B (1998)
Biotin in practical fish-meal based diet for Atlantic salmon Salmo salar L. fry
Aquac. Nutr., 4 (4), 241-247
DOI 10.1046/j.1365-2095.1998.00076.x

Publications 1997

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P (1997)
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
Scand J Infect Dis, 29 (1), 17-22
DOI 10.3109/00365549709008658, PubMed 9112292

Jensenius M, Maeland A, Kvale D, Farstad IN, Vene S, Bruu AL (1997)
[Q-fever imported into Norway]
Tidsskr Nor Laegeforen, 117 (27), 3937-40
PubMed 9441420

Jensenius M, Maeland A, Vene S (1997)
[Endemic typhus imported to Norway]
Tidsskr Nor Laegeforen, 117 (17), 2447-9
PubMed 9265302

Maeland A (1997)
[Screening of pregnant women for toxoplasma infection]
Tidsskr Nor Laegeforen, 117 (8), 1184-5
PubMed 9148496

Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325

Publications 1996

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P (1996)
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
Scand J Infect Dis, 28 (4), 357-9
DOI 10.3109/00365549609037919, PubMed 8893398

Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
[Treatment of hepatitis C]
Tidsskr Nor Laegeforen, 116 (15), 1792-4
PubMed 8693463

Publications 1995

Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
Scand J Gastroenterol, 30 (11), 1119-24
DOI 10.3109/00365529509101617, PubMed 8578174

Publications 1993

Sandven P, Bjørneklett A, Maeland A (1993)
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group
Antimicrob Agents Chemother, 37 (11), 2443-8
DOI 10.1128/AAC.37.11.2443, PubMed 8285631

Publications 1992

Larsen J, Skaug K, Maeland A (1992)
Second-generation anti-HCV tests predict infectivity
Vox Sang, 63 (1), 39-42
DOI 10.1111/j.1423-0410.1992.tb01216.x, PubMed 1384236

NORRBY SR, GOTZSCHE PC, MELANDER H, ANDERSEN P, LAHDEVIRTA J, GUDMUNDSSON S, BRUUN JN, BERGLUND O, SKINHOJ P, GERSTOFT J, THYBO S, GIEMSING P, SOEBERG B, ISAGER H, MOLLER A, KROON S, MAELAND A, DOBLOUG JH, FROLAND S, SCHREINER A, HELLUM KB, LINDBACK S, JACOBSSON B, PEHRSON PO, SKOLDENBERG B et al. (1992)
DOUBLE-BLIND DOSE-RESPONSE STUDY OF ZIDOVUDINE IN AIDS AND ADVANCED HIV-INFECTION
Br. Med. J., 304 (6818), 13-17

Publications 1991

Larsen J, Hetland G, Skaug K, Maeland A (1991)
[Viral hepatitis and blood transfusion]
Tidsskr Nor Laegeforen, 111 (7), 825-8
PubMed 1850559

Larsen J, Skaug K, Maeland A, Hetland G, Stoervold G (1991)
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis
Transfus Med, 1 (1), 13-6
DOI 10.1111/j.1365-3148.1991.tb00003.x, PubMed 9259821

Maeland A (1991)
[Cutaneous leishmaniasis]
Tidsskr Nor Laegeforen, 111 (29), 3512-4
PubMed 1796438

MAELAND A (1991)
SYSTEMIC CANDIDA INFECTIONS
Curr. Med. Res. Opin., 12 1, 26-31

Publications 1989

MAELAND A, SKAUG K, STORVOLD G, KITTELSEN P (1989)
REACTIVATION OF HEPATITIS-B
Lancet, 1 (8646), 1083

Publications 1988

Maeland A (1988)
[Acute HIV disease]
Tidsskr Nor Laegeforen, 108 (22), 1619-20, 1654
PubMed 3413748